Publication | Closed Access

Gastrointestinal health care resource utilization with chronic use of COX-2-specific inhibitors versus traditional NSAIDs1 1The Institute for Effectiveness Research, LLC, is a subsidiary of Medco Health Solutions, Inc., a Merck Company.

Medco Health SolutionsMerck CompanyHealth PolicyClinical EffectivenessGastrointestinal PharmacologyCox-2-specific InhibitorsPharmacologyGastroenterologyOutcomes ResearchPharmacotherapyMedicinePharmacoepidemiologyDigestive System Diseases